类风湿关节炎患者对药物治疗的满意度:一个未满足的需求。

IF 1.4 Q3 RHEUMATOLOGY
Reumatologia Pub Date : 2023-01-01 DOI:10.5114/reum/161575
Saoussen Miladi, Wiem Belhadj, Hiba Boussaa, Makhlouf Yasmine, Zakraoui Leith, Kawther Ben Abdelghani, Alia Fazaa, Ahmed Laatar
{"title":"类风湿关节炎患者对药物治疗的满意度:一个未满足的需求。","authors":"Saoussen Miladi,&nbsp;Wiem Belhadj,&nbsp;Hiba Boussaa,&nbsp;Makhlouf Yasmine,&nbsp;Zakraoui Leith,&nbsp;Kawther Ben Abdelghani,&nbsp;Alia Fazaa,&nbsp;Ahmed Laatar","doi":"10.5114/reum/161575","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Shared decision-making between rheumatologists and patients has become an overarching principle in current treatment recommendations in rheumatoid arthritis (RA). Therefore, in the present study, we aimed to assess the satisfaction of patients with RA with their treatment and to investigate the associated factors.</p><p><strong>Material and methods: </strong>A cross-sectional study was carried out in the Rheumatology Department of Mongi Slim Hospital. We included adults with RA receiving their current disease-modifying anti-rheumatic drugs for at least 12 months.Satisfaction among patients was assessed by the Treatment Satisfaction Questionnaire for Medication (TSQM) and it was defined by a score ≥ 80%. The factors indirectly influencing patient satisfaction that were assessed were: satisfaction with medical care management, disease activity, functional impact, professional impact, and the impact of RA. Multivariable regression analysis was applied to determine the predictors of satisfaction.</p><p><strong>Results: </strong>We included 70 patients (63 female/7 male) with a mean age of 57.8 ±10.6 years. The mean disease duration was 13.71 ±7.2 years.Mean TSQM scores were 65.42 ±14.77 for convenience, 68.71 ±18 for effectiveness, 70.60 ±24.5 for side effects, and 67.95 ±17.10 for global satisfaction. Satisfaction rates were: 20% for convenience, 39% for effectiveness, 46% for side effects and 30% for global satisfaction.In multivariable analysis, the predictors of global dissatisfaction were Rheumatoid Arthritis Impact of Disease (RAID) overall score (<i>p</i> = 0.003) and the degree of physical difficulties (<i>p</i> = 0.001). Satisfaction with the physician was correlated with better global satisfaction (<i>p</i> = 0.029). Difficulties in adapting to RA (<i>p</i> = 0.043) and current treatment with biologics (<i>p</i> = 0.027) were predictors of dissatisfaction with convenience. Predictors of dissatisfaction with efficiency were the RAID overall score (<i>p</i> = 0.032) and the difficulties of adapting to RA (<i>p</i> = 0.013). The predictors of satisfaction with side effects were a lower degree of interference with domestic work (<i>p</i> = 0.02) and better involvement of the patient in the treatment decision (<i>p</i> = 0.014).</p><p><strong>Conclusions: </strong>The satisfaction with the attending physician, the participation in the treatment decision, and the impact of RA seem to influence treatment satisfaction the most. These data suggest that a better understanding of patients' medical needs and preferences would improve satisfaction outcomes.</p>","PeriodicalId":21312,"journal":{"name":"Reumatologia","volume":null,"pages":null},"PeriodicalIF":1.4000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/7f/27/RU-61-161575.PMC10044033.pdf","citationCount":"0","resultStr":"{\"title\":\"Patient satisfaction with medication in rheumatoid arthritis: an unmet need.\",\"authors\":\"Saoussen Miladi,&nbsp;Wiem Belhadj,&nbsp;Hiba Boussaa,&nbsp;Makhlouf Yasmine,&nbsp;Zakraoui Leith,&nbsp;Kawther Ben Abdelghani,&nbsp;Alia Fazaa,&nbsp;Ahmed Laatar\",\"doi\":\"10.5114/reum/161575\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Introduction: </strong>Shared decision-making between rheumatologists and patients has become an overarching principle in current treatment recommendations in rheumatoid arthritis (RA). Therefore, in the present study, we aimed to assess the satisfaction of patients with RA with their treatment and to investigate the associated factors.</p><p><strong>Material and methods: </strong>A cross-sectional study was carried out in the Rheumatology Department of Mongi Slim Hospital. We included adults with RA receiving their current disease-modifying anti-rheumatic drugs for at least 12 months.Satisfaction among patients was assessed by the Treatment Satisfaction Questionnaire for Medication (TSQM) and it was defined by a score ≥ 80%. The factors indirectly influencing patient satisfaction that were assessed were: satisfaction with medical care management, disease activity, functional impact, professional impact, and the impact of RA. Multivariable regression analysis was applied to determine the predictors of satisfaction.</p><p><strong>Results: </strong>We included 70 patients (63 female/7 male) with a mean age of 57.8 ±10.6 years. The mean disease duration was 13.71 ±7.2 years.Mean TSQM scores were 65.42 ±14.77 for convenience, 68.71 ±18 for effectiveness, 70.60 ±24.5 for side effects, and 67.95 ±17.10 for global satisfaction. Satisfaction rates were: 20% for convenience, 39% for effectiveness, 46% for side effects and 30% for global satisfaction.In multivariable analysis, the predictors of global dissatisfaction were Rheumatoid Arthritis Impact of Disease (RAID) overall score (<i>p</i> = 0.003) and the degree of physical difficulties (<i>p</i> = 0.001). Satisfaction with the physician was correlated with better global satisfaction (<i>p</i> = 0.029). Difficulties in adapting to RA (<i>p</i> = 0.043) and current treatment with biologics (<i>p</i> = 0.027) were predictors of dissatisfaction with convenience. Predictors of dissatisfaction with efficiency were the RAID overall score (<i>p</i> = 0.032) and the difficulties of adapting to RA (<i>p</i> = 0.013). The predictors of satisfaction with side effects were a lower degree of interference with domestic work (<i>p</i> = 0.02) and better involvement of the patient in the treatment decision (<i>p</i> = 0.014).</p><p><strong>Conclusions: </strong>The satisfaction with the attending physician, the participation in the treatment decision, and the impact of RA seem to influence treatment satisfaction the most. These data suggest that a better understanding of patients' medical needs and preferences would improve satisfaction outcomes.</p>\",\"PeriodicalId\":21312,\"journal\":{\"name\":\"Reumatologia\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":1.4000,\"publicationDate\":\"2023-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/7f/27/RU-61-161575.PMC10044033.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Reumatologia\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.5114/reum/161575\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"RHEUMATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Reumatologia","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5114/reum/161575","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"RHEUMATOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

风湿病学家和患者之间的共同决策已成为目前类风湿关节炎(RA)治疗建议的首要原则。因此,在本研究中,我们旨在评估RA患者对其治疗的满意度,并探讨相关因素。材料与方法:横断面研究在蒙古斯林医院风湿病科进行。我们纳入了接受当前改善疾病的抗风湿药物治疗至少12个月的成人RA患者。采用药物治疗满意度问卷(TSQM)评估患者满意度,评分≥80%。间接影响患者满意度的因素被评估为:对医疗护理管理的满意度、疾病活动性、功能影响、专业影响和RA的影响。采用多变量回归分析确定满意度的预测因子。结果:纳入70例患者(女性63例/男性7例),平均年龄57.8±10.6岁。平均病程13.71±7.2年。TSQM评分中,便利性评分为65.42±14.77,有效性评分为68.71±18,副作用评分为70.60±24.5,整体满意度评分为67.95±17.10。满意度为:方便性20%,有效性39%,副作用46%,整体满意度30%。在多变量分析中,总体不满意度的预测因子是类风湿关节炎疾病影响(Rheumatoid Arthritis Impact of Disease, RAID)总分(p = 0.003)和身体困难程度(p = 0.001)。对医生的满意度与更好的整体满意度相关(p = 0.029)。适应RA的困难(p = 0.043)和目前使用生物制剂的治疗(p = 0.027)是对便利性不满意的预测因素。对效率不满意的预测因子是RAID总分(p = 0.032)和适应RA的困难(p = 0.013)。不良反应满意度的预测因子为对家务的干扰程度较低(p = 0.02)和患者更好地参与治疗决策(p = 0.014)。结论:对主治医师的满意度、对治疗决策的参与程度、对RA的影响程度对治疗满意度影响最大。这些数据表明,更好地了解患者的医疗需求和偏好将提高满意度结果。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Patient satisfaction with medication in rheumatoid arthritis: an unmet need.

Introduction: Shared decision-making between rheumatologists and patients has become an overarching principle in current treatment recommendations in rheumatoid arthritis (RA). Therefore, in the present study, we aimed to assess the satisfaction of patients with RA with their treatment and to investigate the associated factors.

Material and methods: A cross-sectional study was carried out in the Rheumatology Department of Mongi Slim Hospital. We included adults with RA receiving their current disease-modifying anti-rheumatic drugs for at least 12 months.Satisfaction among patients was assessed by the Treatment Satisfaction Questionnaire for Medication (TSQM) and it was defined by a score ≥ 80%. The factors indirectly influencing patient satisfaction that were assessed were: satisfaction with medical care management, disease activity, functional impact, professional impact, and the impact of RA. Multivariable regression analysis was applied to determine the predictors of satisfaction.

Results: We included 70 patients (63 female/7 male) with a mean age of 57.8 ±10.6 years. The mean disease duration was 13.71 ±7.2 years.Mean TSQM scores were 65.42 ±14.77 for convenience, 68.71 ±18 for effectiveness, 70.60 ±24.5 for side effects, and 67.95 ±17.10 for global satisfaction. Satisfaction rates were: 20% for convenience, 39% for effectiveness, 46% for side effects and 30% for global satisfaction.In multivariable analysis, the predictors of global dissatisfaction were Rheumatoid Arthritis Impact of Disease (RAID) overall score (p = 0.003) and the degree of physical difficulties (p = 0.001). Satisfaction with the physician was correlated with better global satisfaction (p = 0.029). Difficulties in adapting to RA (p = 0.043) and current treatment with biologics (p = 0.027) were predictors of dissatisfaction with convenience. Predictors of dissatisfaction with efficiency were the RAID overall score (p = 0.032) and the difficulties of adapting to RA (p = 0.013). The predictors of satisfaction with side effects were a lower degree of interference with domestic work (p = 0.02) and better involvement of the patient in the treatment decision (p = 0.014).

Conclusions: The satisfaction with the attending physician, the participation in the treatment decision, and the impact of RA seem to influence treatment satisfaction the most. These data suggest that a better understanding of patients' medical needs and preferences would improve satisfaction outcomes.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Reumatologia
Reumatologia Medicine-Rheumatology
CiteScore
2.70
自引率
0.00%
发文量
44
审稿时长
10 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信